[Federal Register Volume 88, Number 29 (Monday, February 13, 2023)]
[Notices]
[Pages 9288-9289]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-02970]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Notice of Closed Meeting

    Pursuant to 5 U.S.C. 1009(d), notice is hereby given of the 
following meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as 
amended, and the Determination of the Director, Strategic Business 
Initiatives Unit, Office of the Chief Operating Officer, CDC, pursuant 
to Public Law 117-286. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.
    Name of Committee: Disease, Disability, and Injury Prevention and 
Control Special Emphasis Panel (SEP)--RFA-PS23-001, Increasing PrEP Use 
Among Disproportionately Affected Populations in the United States and 
RFA-PS23-003, Exploring Preferences for Long-Acting Antiretroviral 
Therapies (LA-ART) in a Community-Based Sample of Priority Populations 
Living with HIV Who are Disproportionately Affected.
    Date: May 11-12, 2023.
    Time: 10 a.m.-5 p.m. (EDT).
    Place: Teleconference, Centers for Disease Control and Prevention, 
Room 1077, 8 Corporate Blvd., Atlanta, GA 30329.
    Agenda: To review and evaluate grant applications.
    For Further Information Contact: Gregory Anderson, M.S., M.P.H., 
Scientific Review Officer, National Center for HIV, Viral Hepatitis, 
STD, and TB Prevention, CDC, 1600 Clifton Road NE, Mailstop US8-1, 
Atlanta, Georgia 30329, Telephone: (404) 718-8833, Email: 
[email protected].
    The Director, Strategic Business Initiatives Unit, Office of the 
Chief Operating Officer, Centers for Disease Control and Prevention, 
has been delegated the authority to sign Federal Register notices 
pertaining to announcements of meetings and other committee management 
activities, for both the Centers for Disease Control and

[[Page 9289]]

Prevention and the Agency for Toxic Substances and Disease Registry.

Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief 
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2023-02970 Filed 2-10-23; 8:45 am]
BILLING CODE 4163-18-P